hereditary haemochromatosis type hferelated genetic disorder characterized excessive intestinal absorption dietary iron resulting pathological increase total body iron humans like animals means excrete excess exception menstruation average woman results loss mg excess iron accumulates tissues organs disrupting normal function susceptible organs include liver heart pancreas skin joints gonads thyroid pituitary gland patients present cirrhosis polyarthropathy hypogonadism heart failure five types hereditary hemochromatosis type caused mutated genes hereditary hemochromatosis type frequent unique related hfe gene common among northern european ancestry particular celtic disease follows autosomal recessive pattern inheritance meaning individual must inherit two copies mutated gene involved cell develop cases person autosomal recessive condition parents act carriers carriers possess one copy mutated gene manifest signs symptoms associated disease referred carriers unaffected carrier parents play integral role transmitting one copy mutated gene child ultimately develops disease however carriers may experience iron overload later stage certain factors come play still cases remain asymptomatic throughout lives unless genetic environmental factors contribute excessive iron accumulation within haemochromatosis protean manifestations ie often presenting signs symptoms suggestive diagnoses affect specific organ systems many signs symptoms uncommon patients hereditary form haemochromatosis show overt signs disease premature morbidity diagnosed early often condition diagnosed presently classic triad cirrhosis bronze skin diabetes less common earlier common clinical manifestations less common findings including hereditary hemochromatosis hh hhc males usually diagnosed forties fifties women decades later menopause severity clinical disease varies considerably evidence suggests hereditary haemochromatosis patients affected liver ailments hepatitis alcoholic liver disease worse liver disease either condition alone also juvenile form primary haemochromatosis hemochromatosis type present childhood consequences iron overloadcitation needed iron stored liver pancreas heart longterm effects haemochromatosis organs serious even fatal since liver primary storage area iron naturally accumulates excess iron time likely damaged iron overload toxins may accumulate blood eventually affect mental functioning due increased risk hepatic encephalopathy together increase risk liver cancer one three persons excess iron heart interferes ability circulate enough blood number problems occur including potentially fatal congestive heart failure condition may reversible haemochromatosis treated excess iron stores reduced arrhythmia abnormal heart rhythm cause heart palpitations chest pain lightheadedness occasionally lifethreatening condition often reversed treatmentcitation needed pancreas also stores iron important bodys mechanisms sugar metabolism diabetes affects way body uses blood sugar glucose diabetes turn leading cause new blindness adults may involved kidney failurecitation needed haemochromatosis may lead cirrhosis complications including bleeding dilated veins esophagus esophageal varices stomach gastric varices severe fluid retention abdomen ascites severity periodontal disease associated high transferrin saturation haemochromatosis regulation dietary iron absorption complex understanding incomplete one bettercharacterized genes responsible hereditary haemochromatosis chromosome codes hepcidin protein participates regulation iron absorption hfe gene three often observed genetic worldwide prevalence rates minor allele frequencies allele transition point mutation guanine adenine nucleotide hfe resulting missense mutation replaces cysteine residue position tyrosine amino heterozygotes either allele manifest clinical iron overload two alleles makes compound heterozygous haemochromatosis puts greatly risk storing excess iron homozygosity genetic variant common genotype responsible clinical iron accumulation though heterozygosity variants socalled compound heterozygotes results clinically evident iron considerable debate exists regarding probability clinical expression trait given clinical disease males homozygous hfe show least one manifestation ironstorage disease middle individuals relevant genetic variants may never develop iron overload phenotypic expression present homozygotes less going experience severe iron overload organ variant gene polymorphism changes may clinical study homozygosity associated elevated mean ferritin level documented iron overload people one copy alteration heterozygous carriers genotype unlikely cause clinical presentation predictable risk iron besides two studies revealed frequency homozygous heterozygous variant significantly higher elite endurance athletes comparing ethnically matched controls associated high male patient susceptible genotype accumulates iron different rates depending iron intake exact nature genetic variant presence insults liver alcohol viral disease degree liver organs affected highly variable dependent factors comorbidities well age studied manifestations penetrance differs populations diseasecausing genetic variants hfe gene account cases nontransfusion iron overloadmedical citation needed gene closely linked locuscitation needed since regulation iron metabolism still poorly understood clear model haemochromatosis operates still available working model describes defect hfe gene mutation puts intestinal absorption iron overdrive normally hfe facilitates binding transferrin irons carrier protein blood transferrin levels typically elevated times iron depletion low ferritin stimulates release transferrin liver transferrin high hfe works increase intestinal release iron blood hfe mutated intestines perpetually interpret strong transferrin signal body deficient iron leads maximal iron absorption ingested foods iron overload tissues however hfe part story since many patients mutated hfe manifest clinical iron overload patients iron overload normal hfe genotype possible explanation fact hfe normally plays role production hepcidin liver function impaired hfe people abnormal iron regulatory genes reduce absorption iron response increased iron levels body thus iron stores body increase increase iron initially stored ferritin deposited organs haemosiderin toxic tissue probably least partially inducing oxidative iron prooxidant thus haemochromatosis shares common symptomology eg cirrhosis dyskinetic symptoms prooxidant diseases wilsons disease chronic manganese poisoning hyperuricaemic syndrome dalmatian dogs latter also experience bronzingcitation needed diagnosis haemochromatosis often made following incidental finding routine blood screening elevated serum liver enzymes elevation transferrin saturation elevated serum ferritin arthropathy stiff joints diabetes fatigue may presenting serum ferritin fasting transferrin saturation commonly used screening haemochromatosis transferrin binds iron responsible iron transport measuring ferritin provides crude measure iron stores body fasting transferrin saturation values excess serum ferritin ugl males ugl females recognized threshold evaluation source says normal values males ngml female fasting transferrin saturation better test detect transferrin saturation greater suggestive homozygosity mutations hfe ferritin protein synthesized liver primary form iron storage within cells tissues measuring ferritin provides crude estimate wholebody iron stores though raised many conditions particularly inflammatory conditions examples causes raised serum ferritin include limited infection chronic alcohol consumption mainly liver disease cancer porphyria hemophagocytic lymphohistiocytosis hyperthyroidism obesity metabolic syndrome diabetes several blood transfusions many iron supplements aceruloplasminemia atransferrinemia hyperferritinemia cataract syndrome others proinflammatory states account raised serum ferritin excess ngml blood almost always attributable haemochromatosiscitation needed blood tests routinely performed include blood count renal function liver enzymes electrolytes glucose andor oral glucose tolerance testcitation needed liver biopsies involve taking sample tissue liver using thin needle amount iron sample quantified compared normal evidence liver damage especially cirrhosis measured microscopically formerly way confirm diagnosis haemochromatosis measures transferrin ferritin along history considered adequate determining presence malady risks biopsy include bruising bleeding infection history measures transferrin ferritin point haemochromatosis whether liver biopsy still necessary quantify amount accumulated iron mribased testing noninvasive accurate alternative measure liver iron clinically disease may silent characteristic radiological features may point diagnosis increased iron stores organs involved especially liver pancreas result characteristic findings unenhanced ct decreased signal intensity mri scans haemochromatosis arthropathy includes degenerative osteoarthritis chondrocalcinosis distribution arthropathy distinctive unique frequently affecting second third metacarpophalangeal joints arthropathy therefore early clue diagnosis haemochromatosiscitation needed based history physician might consider specific tests monitor organ dysfunction echocardiogram heart failure blood glucose monitoring patients haemochromatosis diabetescitation needed american association study liver diseases suggests following three stages condition identified european association study liver individuals stage necessarily progress next stage end stage disease common males causes excess iron accumulation exist considered haemochromatosis type diagnosed standard diagnostic measures haemochromatosis transferrin saturation ferritin tests part routine medical testing screening haemochromatosis recommended patient parent child sibling routine screening general population hereditary haemochromatosis generally done mass genetic screening evaluated us preventive services task force among groups recommended genetic screening general population hereditary haemochromatosis likelihood discovering undiagnosed patient clinically relevant iron overload less one although strong evidence shows treatment iron overload save lives patients transfusional iron overload clinical study shown asymptomatic carriers hereditary haemochromatosis treatment venesection phlebotomy provides clinical recently patients suggested screened iron overload using serum ferritin marker serum ferritin exceeds ngml iron overload likely cause early diagnosis vital late effects iron accumulation wholly prevented periodic phlebotomies venesection comparable volume blood phlebotomy bloodletting usually done weekly two weeks interval ferritin levels Î¼gl less prevent iron reaccumulation subsequent phlebotomies normally carried every three four months males twice year females keep serum ferritin venesection possible longterm administration iron chelator deferoxamine desferrioxamine deferasirox deferiprone useful deferoxamine ironchelating compound excretion induced deferoxamine enhanced administration vitamin c used pregnancy breastfeeding due risk defects childcitation needed diet powerful understudied tool prevention iron overload especially western world many foods fortified animal protein relatively convenient inexpensive common people eat recommended dietary allowance iron even single meal example one serving several popular cereals two times rda iron man non menstruating woman menstruating women roughly twice iron requirements man non menstruating woman due monthly loss blood novel experimental approach hereditary haemochromatosis treatment maintenance therapy polymeric polymers particles negligible null systemic biological availability designed form stable complexes git thus limiting uptake ions longterm accumulation although method limited efficacy unlike smallmolecular chelators approach virtually side effects subchronic interestingly simultaneous chelation increases treatment persons symptomatic haemochromatosis somewhat reduced life expectancy compared general population mainly due excess mortality cirrhosis liver cancer patients treated phlebotomy lived longer patients without liver disease diabetes similar survival rate general population haemochromatosis one common heritable genetic conditions people northern europe prevalence disease variable penetration one people demographic carry mutation one genes regulating iron us frequency mutations respectively whereas worldwide frequency mutations respectively mutation allele prevalence mutations ironmetabolism genes varies different populations study unrelated white australians found heterozygous carriers hfe mutation homozygous hfe mutation study population clinically relevant iron overload patients homozygous hfe mutations manifest clinically relevant haemochromatosis see genetics populations lower prevalence genetic mutation clinical disease frequent genetic disease us prevalence nonhispanic white times common genetics studies suggest original haemochromatosis mutation arose single person possibly celtic ethnicity lived generations time dietary iron may scarcer today presence mutant allele may provided evolutionary advantage maintaining higher iron levels bloodcitation needed distribution variant noted various countries nonhfe associated hemochromatosis haemochromatosis type haemochromatosis type haemochromatosis type haemochromatosis type discovered mediterranean countries side northern european ancestry closely linked hereditary hemochromatosis disease hfe one study irish patients hfe mutation homozygotic mutation hjv gene produces hemojuvelin protein widely distributed central europe term haemochromatosis used different sources many different ways often used imply association hfe gene many years hfe known gene associated haemochromatosis term hereditary haemochromatosis used describe haemochromatosis type however many different genetic associations condition known older text general audience likely hfe implied haemochromatosis also used contexts genetic cause iron accumulation known cases however condition thought due diet environment later linked genetic polymorphism african iron overloadcitation needed virchow described golden brown granular pigment soluble sulfuric acid produced red ash disease first described armand trousseau report diabetes patients presenting bronze pigmentation two years later perls developed first practical method analysis iron tissue despite trousseau associating diabetes iron accumulation recognition infiltration pancreas iron might disrupt endocrine function resulting diabetes made friedrich daniel von recklinghausen english gerontologist joseph sheldon described cases haemochromatosis established name disorder detailed monograph despite lacking modern molecular techniques accessible today came accurate conclusions describe haemochromatosis disease inborn error metabolism inherited disorder increase absorption iron thus cause tissue damage due iron deposition moreover rejected theories alcohol drug factors contribute clinical case series indicated haemochromatosis common macdonald pathologist boston city hospital diverted attention away true cause haemochromatosis believed haemochromatosis nutritional condition observed many drunken patients irish period time investigators reported additional evidence suggesting genetic factor could play central role absorption iron people haemochromatosis however alcohol consumption known increase risk liver injury haemochromatosis finding consistent concept excess iron metabolism primary cause haemochromatosis finally marcel simon collaborators confirmed haemochromatosis autosomal recessive disorder link human leukocyte antigen hla region genome took years researchers mercator genetics effectively identify clone haemochromatosis genes using positional cloning feder et al identified hfe major histocompatibility complex mhc gene found patients homozygosity missense mutation hfe finally several groups reported findings series patients haemmochromatosis discovered existence mutation cases discovery led improved clinical medicine liver disease httpsenwikipediaorgwikihereditaryhaemochromatosis